Bioavailability/Bioequivalence Strategies for MPTs – Feasibility and Risks
This live webinar focused on critical conversations around bioavailability and bioequivalence strategies for MPTs, including feasibility and risks. The webinar featured a presentation by Charles DiLiberti of Montclair Bioequivalence Services and a facilitated discussion with Laneta Dorflinger of FHI 360 and Joseph Romano of the IMPT.
January 2017
Click for full info +Bioavailability/Bioequivalence Strategies for MPTs – Feasibility and Risks
 | 26 January 2017 |
In this Blog :
Full Info:
Resource Type:
Citation:
Live webinar featuring an overview of critical issues related to bioequivalence and bioavailability for MPTs.
Authors: DiLiberti,C., Dorflinger, L., Romano, J.
Product type(s):
- MPTs
Topic(s):
- MPTs
- Risk